S have been a primary target when searching for biomarker candidates in AD and other neurodegenerative diseases (30, 40) supported also by the use of phospho-tau and A (1?42) as diagnostic markers in the CSF. One key advantage of using proteomics is that many proteins and protein variants (such as isoforms or post-translational modification of proteins) can be simultaneously characterized and quan